Top 20 US Stock Deals: Lilly Weight Loss Medicine Approved, Stock Price Set a New Record
邹高清
发表于 2023-11-9 12:57:22
1373
0
0
Top 20 US Stocks in Trading Volume: Lilly slimming pills approved, with stock price reaching a historic high. 6th place Lilly closed up 3.2%, with stock price reaching a historic high, with a transaction volume of $4.736 billion. On Wednesday (November 8th) local time, the US Food and Drug Administration (FDA) announced on its official website that it has approved Lilly's Tirzepatide injection for long-term weight management under the trade name "Zepbound".
CandyLake.com is an information publishing platform and only provides information storage space services.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
You may like
- Strong demand for AI drives Broadcom's profits beyond expectations, causing its stock price to soar 15% after hours
- Top 20 US Stock Transactions: Adobe's Poor Performance, Stock Price Falls 13.7%
- Top 20 US stock transactions: Tesla may no longer report autonomous driving accidents, stock price hits historic high
- Bitcoin stands at $105000, setting a new historical high!
- Micron Technology's stock price plummeted by about 18% after the market closed
- Goldman Sachs: Lowering Micron Technology's Target Stock Price to $128
- Lilly's stock price surged 10% before the US stock market opened
- The three major indexes of the US stock market closed higher, the Nasdaq returned to 20000 points, Tesla rose more than 7%, and Apple hit a new high again
- Top 20 US stock transactions: Apple hits historic high for fourth consecutive trading day, with a total market value of nearly $4 trillion
- BeiGene and BeiZeAn are approved for new indications in the United States